Sex-Specific Predictors of Long-Term Mortality in Elderly Patients with Ischemic Cardiomyopathy

Hyun Ju Yoon1, Kye Hun Kim1, Nuri Lee1

  • 1Department of Cardiology, Chonnam National University Medical School/Hospital, Gwangju 61469, Republic of Korea.

Insights

Predictors of mortality in elderly patients with ischemic cardiomyopathy differ by sex. Low ejection fraction impacts both, but other factors like diabetes, anemia, and medication use are sex-specific, requiring tailored approaches for better survival.

Area of Science:

  • Cardiology
  • Geriatrics
  • Clinical Research

Background:

  • Ischemic heart failure (HF) is a leading cause of global morbidity and mortality.
  • Sex-specific mortality predictors in elderly patients with ischemic cardiomyopathy (ICMP) remain understudied.
  • Understanding these differences is crucial for targeted interventions and improved patient outcomes.

Purpose of the Study:

  • To investigate and compare sex-specific predictors of long-term mortality in elderly patients diagnosed with ICMP.
  • To identify factors that independently influence survival rates in male versus female patients with ICMP.
  • To inform sex-specific treatment strategies for improving long-term survival in this vulnerable population.

Main Methods:

  • A cohort of 536 elderly patients (over 65 years) with ICMP was followed for a mean of 5.4 years.
  • Mortality events were recorded, and univariate and multivariate analyses were performed to identify predictors.
  • Statistical comparisons were made between male and female patient subgroups to determine sex-specific associations.

Main Results:

  • Low ejection fraction was an independent predictor of mortality in both sexes.
  • In females, diabetes, elevated e/e', elevated pulmonary artery systolic pressure, anemia, and non-use of beta-blockers or angiotensin receptor blockers predicted mortality.
  • In males, hypertension, elevated creatinine, and non-use of statins were independent predictors of mortality.

Conclusions:

  • Mortality predictors in elderly ICMP patients exhibit significant sex differences.
  • Systolic dysfunction affects both sexes, while diastolic dysfunction, specific medications (beta-blockers, ARBs in females; statins in males) play crucial sex-specific roles.
  • Implementing sex-specific management strategies is essential for enhancing long-term survival in elderly patients with ICMP.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
40
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133